Revive Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.41 M
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 36.70 Cr
- Satisfied Charges ₹ 100.11 Cr
- Revenue Growth -24.02%
- Profit Growth -22.83%
- Ebitda 71.14%
- Net Worth 8.60%
- Total Assets 7.88%
About Revive Pharmaceuticals
Revive Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 1996 and has a history of 28 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Revive Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.41 M.
The company currently has active open charges totaling ₹36.70 Cr. The company has closed loans amounting to ₹100.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhusudan Ruia and Mahendra Kumawat serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1996PTC096954
-
Company No.
096954
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Revive Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhusudan Ruia
|
Director | 06-Feb-2004 | Current |
|
Mahendra Kumawat
|
Director | 17-Sep-2020 | Current |
Financial Performance of Revive Pharmaceuticals.
Revive Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.02% decrease. The company also saw a substantial fall in profitability, with a 22.83% decrease in profit. The company's net worth moved up by a moderate rise of 8.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Revive Pharmaceuticals?
Unlock access to Revive Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Agio Pharmaceuticals LimitedMadhusudan Ruia and Mahendra Kumawat are mutual person
-
Bhakti Enterprises LimitedMadhusudan Ruia and Mahendra Kumawat are mutual person
-
Kimaya Property Private Limited
Madhusudan Ruia and Mahendra Kumawat are mutual person
-
Genome Pharmaceuticals And Chemicals Private Limited
Mahendra Kumawat is a mutual person
Charges (Loans)
₹367.00 M
₹1,001.10 M
Charges Breakdown by Lending Institutions
- Others : 36.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2011 | Others | ₹36.70 Cr | Open |
| 06 Apr 2022 | Others | ₹3.08 Cr | Satisfied |
| 23 Jun 2021 | Others | ₹5.68 Cr | Satisfied |
| 25 Jul 2012 | Others | ₹36.00 Cr | Satisfied |
| 22 Aug 2000 | State Bank Of India | ₹55.35 Cr | Satisfied |
How Many Employees Work at Revive Pharmaceuticals?
Unlock and access historical data on people associated with Revive Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Revive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revive Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
